As of 3:59pm ET
| -0.37 / -2.46%|
The 5 analysts offering 12-month price forecasts for Insmed Inc have a median target of 23.00, with a high estimate of 35.00 and a low estimate of 18.00. The median estimate represents a +56.89% increase from the last price of 14.66.
The current consensus among 6 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.